Varicella-zoster virus infection under administration of ganciclovir after allogeneic bone marrow transplantation

Scandinavian Journal of Infectious Diseases

Volumn 38, Issue 3, 2006, Pages 227-228

  Mori, Takehiko ^a   Shimizu, Takayuki ^a   Yamazaki, Rie ^a   Aisa, Yoshinobu ^a   Nakazato, Tomonori ^a   Ikeda, Yauso ^a   Okamoto, Shinichiro ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; FLUDARABINE; GANCICLOVIR; MELPHALAN; METHOTREXATE; PREDNISONE; TSUKUBAENOLIDE; VALACICLOVIR; VINCRISTINE SULFATE;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RELAPSE; CASE REPORT; CLINICAL FEATURE; CYTOMEGALOVIRUS INFECTION; DRUG DOSE REGIMEN; DRUG MEGADOSE; FEMALE; GASTROENTERITIS; GRANULOCYTOPENIA; HERPES ZOSTER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NONHODGKIN LYMPHOMA; VARICELLA ZOSTER VIRUS; VIRUS ISOLATION;

ADULT; ANTIVIRAL AGENTS; BONE MARROW TRANSPLANTATION; FEMALE; GANCICLOVIR; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; TRANSPLANTATION, HOMOLOGOUS; VIRUS ACTIVATION;

EID: 33644595801     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540500348986     Document Type: Article

References (10)

1. Locksley, RM and Flournoy, N and Sullivan, KM and Myers, JD. (1985) Infection with varicella-zoster virus after bone marrow transplantation J Infect Dis, 152, pp. 1172 - 1178.
2. Arvin, AM. (2000) Varicella-zoster virus: Pathogenesis, immunity, and clinical management in hematopoietic cell transplant recipients Biol Blood Marrow Transplant, 6, pp. 219 - 230.
3. Crumpacker, CS. (1996) Ganciclovir N Engl J Med, 335, pp. 721 - 729.
4. Field, AK and Davies, ME and DeWitte, C and Perry, HC and Liou, R and Gamershausen and (1983) 9{[2-Hydroxy-1-(hydroxymethyl) ethoxy]methyl}guanine: A selective inhibitor of herpes group virus replication Proc Natl Acad Sci, 80, pp. 4139 - 4143.
5. Steer C.V. Szer J. Sasadeuz Matthews J.P. Beresford J.A. Grigg A. 2000 Varicella-zoster infection after allogeneic bone marrow transplantation: Incidence, risk factors and prevention with low-dose acyclovir and ganciclovir. Bone Marrow Transplant 25 657-664
6. Kanda Y. Mineishi S. Saito T. Saito A. Yamada S. Ohnishi M. 2001 Long-term acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation Bone Marrow Transplant 28 689-692
7. Jacobson M.A. Berger T.G. Fikrig S. 1990 Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS) Ann Intern Med 112 187-191
8. Happenjans W.B. Bibler M.R. Orme R.L. Solinger A.M. 1990 Prolonged cutaneuous herpes zoster in acquired immunodeficiency syndrome Arch Dermatol 126 1048-1050
9. Koyano S. Suzutani T. Yoshida I. Azuma M. 1996 Analysis of phosphorylation pathways of antiherpesvirus nucleosides by varicella-zoster virus-specific enzymes Antimicrob Agents Chemother 40 920 - 923
10. Whitely, RJ and Grann, JW, Jr. (1995) Herpes zoster in patients with human immunodeficiency virus infection- an ever-expanding spectrum of disease J Infect Dis, 24, pp. 989 - 990.